4 Stocks to Watch on Dendreon Earnings

Other smaller companies could move right along with DNDN

    View All  

Galena Biopharma

Click to Enlarge
Market Cap: $45M

Description from Yahoo! Finance

Galena Biopharma (NASDAQ:GALE), a biotechnology company, engages in discovering, developing and commercializing innovative therapies addressing unmet medical needs using targeted bio therapeutics. The company is pursuing the development of cancer therapeutics using peptide-based immunotherapeutics, including its main product candidate, NeuVax (E75) for the treatment of various cancers.

Click to Enlarge
Technical Analysis

The stock is making a series of higher highs and higher lows and currently is forming a bull flag that should resolve to the upside on a trade through $1.15.

As of this writing, Serge Berger did not hold a position in any of the aforementioned securities.

Article printed from InvestorPlace Media, http://investorplace.com/2012/02/4-stocks-to-watch-on-dendreon-earnings-dndn-imuc-agen-cldx-gale/.

©2017 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.